Tissue factor (TF), a cell surface glycoprotein, serves as the cellula
r receptor for either activated or non-activated factor VII [FVII(a)]
and it is the formation of TF-FVII(a) complexes on cell surfaces which
triggers the coagulation cascade in vivo. TF procoagulant functional
expression on cell surfaces can be regulated by at least three distinc
t major mechanisms: (1) transcriptional regulation of TF gene expressi
on; (2) cell membrane alterations in cells expressing TF; and (3) neut
ralization of TF-activated factor VII (FVIIa) activity by plasma inhib
itors. The TF gene, which is not normally expressed in vascular cell t
ypes, can be induced by several pathophysiological stimuli, particular
ly those elaborated upon in inflammation and cancer. However, some of
the stimuli elaborated in these pathological processes, e.g. basic fib
roblast growth factor, suppress the induced expression of TF in endoth
elium. Not all TF molecules expressed on cell surfaces are functional
even though they have the ability to bind to FVII(a). The availability
of anionic phospholipids on cell membranes in the vicinity of TF and
the spatial localization of TF within the cell membrane influence the
functional activity of TF. Once TF-FVII(a) complexes are assembled on
cell surfaces, at least two plasma inhibitors, TF pathway inhibitor an
d antithrombin III play an important role in regulating the TF-FVII(a)
functional activity by inhibiting the activation of factor VII bound
to TF and by inhibiting the catalytic activity of TF-FVIIa complexes.
The availability of heparan sulphate proteoglycans with anticoagulant
activity on cell surfaces plays an important role in enhancing the act
ivity of the inhibitors. This manuscript summarizes the mechanisms by
which TF functional expression on cells is regulated with a particular
emphasis on the recent findings of the authors and their collaborator
s. Blood Coag Fibrinol 9 (suppl 1):S27-S35 (C) 1998 Lippincott-Raven P
ublishers